A 12-week treatment for eosinophilic esophagitis (EoE) in patients 11 years of age and older. EOHILIA has not been shown to be safe and effective for longer than 12 weeks.1

Request an EOHILIA™ representative page



Please fill out the appropriate fields to be contacted by an EOHILIA representative

All fields are required except those marked optional. 

Please send me more information about (check all that apply):
How do you prefer to be contacted?


  1. EOHILIA (budesonide oral suspension) Prescribing Information. Takeda Pharmaceuticals, Inc.